Delivery Order SPE2DB22D2006-SPE2DB24FW0JB
Award Date 5/14/24
Potential Completion Date 5/15/24
Potential Value $1.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,564,530,476 units of Tamsulosin HCl 0.4 mg capsules, a medication used to treat the symptoms of an enlarged prostate. The contract has a ceiling value of $6,483.58 and a completion date of May 8, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation,...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,093.29, is for the delivery of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of May 13, 2024. It is not designated as a set-aside contract. AmerisourceBergen...
- This federal contract award, valued at $1,687.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,564,978,039 units of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a completion date of June 24, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract is valued at $3,433.57 and has a completion date of June 30, 2025. The contract is not designated as a set-aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,479.53, is for the delivery of 1,000 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate. The contract is a Firm Fixed Price Delivery Order with a completion date of February 11, 2025. The award is not designated as a set-aside contract. AmerisourceBergen holds a...
- This federal contract award, valued at $2,202.94, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 1,000 units of the medication Tamsulosin HCL 0.4 mg capsules, which are used to treat an enlarged prostate. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,645,511 units of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a ceiling value of $2,386.37 and is a firm fixed-price delivery order contract that runs through March 21, 2025. The contract is not designated as a...
- This federal contract award, valued at $3,836.76, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,925,451 units of Tamsulosin HCL 0.4 mg capsules, a medication used to treat an enlarged prostate. The contract has a period of performance through March 12, 2024. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,057.83, is for the supply of 1,000 capsules of Tamsulosin Hydrochloride 0.4 mg, a medication used to treat symptoms of an enlarged prostate. The contract has an ultimate completion date of July 19, 2024. This award is part of AmerisourceBergen's larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,385.29 delivery order contract is for the supply of 4,563,500 capsules of Tamsulosin HCL 0.4 mg, a medication used to treat an enlarged prostate gland. The contract has an ultimate completion date of February 1, 2024 and was awarded on January 31, 2024. The contract is a firm fixed price type with no set-aside...